24-27, June, 2023, the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) was?held in Chicago, USA. The SNMMI annual meeting is currently one of the largest and most influential academic conferences in the field of nuclear medicine and molecular imaging around the world, providing an in-depth understanding of the latest developments in research for companies, scientists, technical experts, doctors, pharmacists, laboratory professionals, and others, as well as offering insights into clinical practical applications.

The SNMMI Annual Meeting provided an excellent opportunity to gain in-depth understanding and obtain the latest industry developments, as well as to engage in face-to-face communication with partners. Sinotau, as an innovative pharmaceutical company focusing on the field of radiopharmaceuticals, participated in the meeting and engaged in profound discussions with various partners and industry experts, yielding fruitful results.

At the same time, Sinotau, as the only Chinese invitee, had the honor of participating in the SNMMI Radiopharmaceutical Summit held at the Club in Chicago, USA on 26,June.

The forum invited global leaders and experts in the radiopharmaceutical industry to jointly explore key issues affecting the industry. The topics cover the entire industry chain of radiopharmaceuticals. Participants discussed in depth how to seize opportunities and innovate development around isotope production, product development, supply chain logistics, patient accessibility, financing, partnerships, and intellectual property.